• aTyr Pharma will hold a special stockholder meeting in San Diego, California on Oct. 16, 2026.
• Shareholders will vote on authorizing the board to implement a reverse stock split at a ratio from 1-for-10 to 1-for-50.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aTyr Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001339970-26-000061), on September 11, 2026, and is solely responsible for the information contained therein.